Liver fibrosis is a major global health concern, developing as a result of chronic liver diseases (CLDs) such as viral ...
Gleneagles Hospital Hong Kong (Gleneagles) is excited to be the first private hospital in Asia to offer Histotripsy treatment, the transformative and non-invasive technology that uses high-intensity ...
A father from Seattle, Washington was shocked and overwhelmed after strangers came together to raise more than $150k for him to go through life-saving cancer treatment.
Nature Aging has revealed a promising new drug candidate that may help combat metabolic dysfunction-associated steatotic liver disease (MASLD), a ...
New Zealanders now have funded access to a global standard of care treatment for a form of liver cancer, Hepatocellular Carcinoma (HCC), which, unlike many other cancers has a rapidly increasing rate ...
5d
News-Medical.Net on MSNTargeted nanoparticles show promise in preventing pancreatic cancer spread to the liverPancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...
A new technology from researchers at the California NanoSystems Institute at UCLA is aiming to turn the tables on tumors that ...
Manulife announced today the extension of its strategic partnership with CUHK Medical Centre (CUHKMC), originally established in 2021, as part of its commitment to enhancing access to quality ...
The groundbreaking study demonstrates drug candidate can safely and effectively target and eliminate senescent cells, also known as “zombie cells,” from the liver.
A recent study unveils how stromal interaction molecule 1 (STIM1), a protein involved in calcium signaling, plays a pivotal ...
New data show that external-beam radiation therapy yielded superior local control and progression-free survival vs TACE in patients with hepatocellular carcinoma.
Scientists discovered a way to block hepatitis B infection using an anticancer drug, offering hope for new treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results